
Public health officials have confirmed several fatalities linked to the novel coronavirus.

Public health officials have confirmed several fatalities linked to the novel coronavirus.

Staphylococcus aureus is a major cause of both health care-acquired and community-acquired infections ranging from skin and soft tissue infections to more invasive infections like bacteremia

The investigators of a new observational cohort study on incidence of tetanus and diphtheria in 31 countries have provided data that suggest no benefit associated with performing adult booster vaccinations.

More than half of patients filled a prescription for an antibiotic within 7 days of a dental-related ED visit. Around 40% of these individuals filled a prescription for an opioid.

Measles leave every organ system vulnerable and can lead to a wide range of serious complications, including hepatitis, appendicitis and viral meningitis, according to a new study.

Health officials in King County, Washington, have confirmed a death linked to the novel coronavirus.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of February 23, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

The FDA has approved an application for the first generic of Daraprim (pyrimethamine) tablets for the treatment of toxoplasmosis when used with a sulfonamide.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Preliminary evidence indicates no direct evidence for intrauterine transmission of the SARS-CoV-2 virus from pregnant women with COVID-19 to their infants.

While locally-acquired Chagas disease is rare in the United States, the testing of a blood donation sample led to what is likely the first documented case of the disease in Missouri.

As February comes to an end, we’re looking back at important infectious disease news from the past month.

In addition to meeting its primary endpoint, cefepime-enmetazobactam displayed superiority over piperacillin-tazobactam alongside a comparable safety profile.

Antimicrobial stewardship experts are sharing their favorite tips and identifying myths about antibiotics.

New research pinpoints some of the factors involved in HIV reemergence after cessation of antiretroviral therapy, as well as possible ways to stop the process.

Health officials are investigation an outbreak of E coli in 5 states with a suspected link to clover sprouts served at Jimmy John’s restaurants.

Using enteral vancomycin for C diff prophylaxis may be the key to reducing morbidity and improving outcomes in pediatric and young adult recipients of HSCT.

In models of air transportation networks during the early stages of an outbreak, disease spread could be reduced by up to 38% with improved hand washing at 10 major airports.

Influenza-associated hospitalization rates among children and young adults are considered higher than recent flu seasons.

What can we learn from those who met PUI criteria?

The CDC has confirmed an infection with the virus that causes COVID-19 in California in a person who reportedly did not have relevant travel history or exposure to another known patient with COVID-19

RESTORE-IMI 1 showed a safety difference IMI-REL and IMI+CST when it comes to nephrotoxicity. The team behind a new retrospective study has applied acute kidney injury assessments to the results.

The US Food and Drug Administration has sent the sandwich chain a warning letter over citing involvement in several outbreaks of Salmonella and Escherichia coli over the past 7 years.

Most US cases of dengue came from patients with a history of travel, according to a new report.

An article in Open Forum Infectious Diseases includes advice from and support for fellowship program directors.

Among a cohort of 9 pregnant women who developed COVID-19 pneumonia, there was no evidence of vertical transmission to infants.

Biofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.

Clinicians accustomed to HIPAA guidelines may not be aware of changes in confidentiality when they make contact with school health care services.

The randomized controlled trial will assess the activity of the antiviral remdesivir among hospitalized adults at the University of Nebraska Medical Center.